Company profile
AEBi - Accelerated Evolution Biotechnologies company profile
AEBi is engaged in the discovery and development of therapeutic peptides. AEBi is a development-stage biopharmaceutical company which is engage in the discovery and development of therapeutic peptides has developed a combinatorial biology screening platform technology (IP protected). AEBi was established in the year 2000 by Ilan Morad.
Business identity
- Website
- http://www.aebi-bio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2000-07-01
Headquarters
- Headquarters
- Ness Ziona, Central District, Israel
- Country code
- IL
- Continent
- Asia